Vesselin Mitaksov

Title: Vesselin Mitaksov: Innovator in Immunology

Introduction

Vesselin Mitaksov is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of immunology, particularly through his innovative patent related to MHC class I molecules. His work has implications for vaccination and T cell tracking, showcasing the intersection of molecular biology and immunotherapy.

Latest Patents

Vesselin Mitaksov holds a patent titled "Disulfide trap MHC class I molecules and uses therefor." This patent describes a disulfide trap that comprises an antigen peptide covalently attached to an MHC class I heavy chain molecule by a disulfide bond extending between two cysteines. The invention details configurations such as a disulfide trap single chain trimer (dtSCT), which can consist of a single contiguous polypeptide chain. Upon synthesis in a cell, the disulfide trap oxidizes properly in the endoplasmic reticulum and can be recognized by T cells. Notably, the peptide moiety of the disulfide trap is resistant to displacement by high-affinity competitor peptides, even if the peptide binds the heavy chain relatively weakly. The disulfide trap can be utilized for vaccination, eliciting CD8 T cells, and in multivalent MHC/peptide reagents for the enumeration and tracking of T cells. Additionally, nucleic acids encoding a disulfide trap can be used as DNA vectors for vaccines.

Career Highlights

Vesselin Mitaksov is affiliated with Washington University, where he continues to advance research in immunology. His innovative approach to MHC class I molecules has positioned him as a key figure in the development of new immunotherapeutic strategies.

Collaborations

He has collaborated with notable colleagues such as Ted H Hansen and Daved Henry Fremont, contributing to a rich environment of research and innovation.

Conclusion

Vesselin Mitaksov's work exemplifies the potential of innovative approaches in immunology, particularly through his patented disulfide trap technology. His contributions are paving the way for advancements in vaccination and T cell tracking, highlighting the importance of research in this critical field.